Company Filing History:
Years Active: 2008-2010
Title: Janet L MacPherson: Innovator in Gene Therapy
Introduction
Janet L MacPherson is a prominent inventor based in Leichhardt, Australia. She has made significant contributions to the field of gene therapy, particularly in the modification of hematopoietic progenitor cells. Her work has the potential to impact treatments for various diseases, including HIV.
Latest Patents
Janet holds two patents related to her innovative work. The first patent describes methods for genetic modification of hematopoietic progenitor cells and their uses. This invention focuses on compositions and methods relating to gene therapy, specifically for hematopoietic progenitor cells. It details the processes for obtaining transduced cells and methods for using them to achieve prolonged engraftment of modified hematopoietic cells in human subjects. The invention is particularly relevant for ex vivo gene therapy aimed at treating or preventing HIV infection.
Career Highlights
Janet is currently associated with Johnson & Johnson Research Pty Limited, where she continues to advance her research in gene therapy. Her work is characterized by a commitment to developing innovative solutions that can lead to significant medical breakthroughs.
Collaborations
Throughout her career, Janet has collaborated with notable professionals in her field, including Geoffrey Phillip Symonds and Rafael G Amado. These collaborations have further enriched her research and contributed to the advancement of gene therapy techniques.
Conclusion
Janet L MacPherson is a trailblazer in the field of gene therapy, with a focus on hematopoietic progenitor cells. Her patents and ongoing research hold promise for future medical advancements, particularly in the treatment of HIV.